Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiharu Kitani

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Laryngoscope|January 19, 2012
Transforming growth factor β3 for the prevention of vocal fold scarringSatoshi Ohno, Shigeru Hirano, Shin-ichi Kanemaru, et al.
The Laryngoscope|October 26, 2011
The protective efficacy of basic fibroblast growth factor in radiation-induced salivary gland dysfunction in miceTsuyoshi Kojima, Shin-Ichi Kanemaru, Shigeru Hirano, et al.
Auris, Nasus, Larynx|September 11, 2007
Multifocal hyperfunctioning thyroid carcinoma without metastasesAkiko T Nishida, Shigeru Hirano, Ryo Asato, et al.
The Annals of Otology, Rhinology, and Laryngology|December 17, 2009
Atelocollagen sponge as a stem cell implantation scaffold for the treatment of scarred vocal foldsSatoshi Ohno, Shigeru Hirano, Ichiro Tateya, et al.
Journal of Tissue Engineering and Regenerative Medicine|January 10, 2014
Glottic regeneration with a tissue-engineering technique, using acellular extracellular matrix scaffold in a canine modelMorimasa Kitamura, Shigeru Hirano, Shin-Ichi Kanemaru, et al.
Plos One|November 10, 2012
Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancerSeiji Ishikawa, Ichiro Tateya, Takahiro Hayasaka, et al.
Auris, Nasus, Larynx|March 2, 2022
Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neckShuya Otsuki, Ryusuke Hori, Shogo Shinohara, et al.
Cancers|September 11, 2019
Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck CarcinomaRyusuke Hori, Shogo Shinohara, Tsuyoshi Kojima, et al.
Thyroid : Official Journal of the American Thyroid Association|December 10, 2025
Are Total Thyroidectomy and Adjuvant Radioactive Iodine Treatment Required in All Patients with N1b Intermediate-High Risk Papillary Thyroid Carcinoma?Takashi Fujiwara, Nozomu Kofuji, Yo Kishimoto, et al.
Acta Oto-Laryngologica|September 14, 2017
Adenoid cystic carcinoma of the head and neck: a retrospective multicenter studyShinji Takebayashi, Shogo Shinohara, Hisanobu Tamaki, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Laryngoscope|January 19, 2012
Transforming growth factor β3 for the prevention of vocal fold scarringSatoshi Ohno, Shigeru Hirano, Shin-ichi Kanemaru, et al.
The Laryngoscope|October 26, 2011
The protective efficacy of basic fibroblast growth factor in radiation-induced salivary gland dysfunction in miceTsuyoshi Kojima, Shin-Ichi Kanemaru, Shigeru Hirano, et al.
Auris, Nasus, Larynx|September 11, 2007
Multifocal hyperfunctioning thyroid carcinoma without metastasesAkiko T Nishida, Shigeru Hirano, Ryo Asato, et al.
The Annals of Otology, Rhinology, and Laryngology|December 17, 2009
Atelocollagen sponge as a stem cell implantation scaffold for the treatment of scarred vocal foldsSatoshi Ohno, Shigeru Hirano, Ichiro Tateya, et al.
Journal of Tissue Engineering and Regenerative Medicine|January 10, 2014
Glottic regeneration with a tissue-engineering technique, using acellular extracellular matrix scaffold in a canine modelMorimasa Kitamura, Shigeru Hirano, Shin-Ichi Kanemaru, et al.
Plos One|November 10, 2012
Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancerSeiji Ishikawa, Ichiro Tateya, Takahiro Hayasaka, et al.
Auris, Nasus, Larynx|March 2, 2022
Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neckShuya Otsuki, Ryusuke Hori, Shogo Shinohara, et al.
Cancers|September 11, 2019
Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck CarcinomaRyusuke Hori, Shogo Shinohara, Tsuyoshi Kojima, et al.
Thyroid : Official Journal of the American Thyroid Association|December 10, 2025
Are Total Thyroidectomy and Adjuvant Radioactive Iodine Treatment Required in All Patients with N1b Intermediate-High Risk Papillary Thyroid Carcinoma?Takashi Fujiwara, Nozomu Kofuji, Yo Kishimoto, et al.
Acta Oto-Laryngologica|September 14, 2017
Adenoid cystic carcinoma of the head and neck: a retrospective multicenter studyShinji Takebayashi, Shogo Shinohara, Hisanobu Tamaki, et al.
Pageof 4